# Considering the Possible Role of Pharmacists According to the Presence or Absence of Lifestyle-Related Diseases at the Time of Coronary CT Examination and Trends of Medication Use for These Diseases by Medical Doctors

**Authors:** Erika Miura-Takahashi, Kohei Tashiro, Yuhei Shiga, Yuto Kawahira, Sara Higashi, Yuki Otsu, Hidetoshi Kamimura, Shin-ichiro Miura

PMC · DOI: 10.3390/pharmacy12040099 · 2024-06-27

## TL;DR

The study explores how pharmacists can help manage lifestyle-related diseases in patients with coronary artery disease by analyzing medication use and disease control.

## Contribution

Highlights pharmacists' potential role in optimizing drug combinations for lifestyle-related diseases in coronary CT patients.

## Key findings

- Patients with lifestyle-related diseases had a significantly higher rate of coronary artery disease.
- Control of hypertension, dyslipidemia, and diabetes was poor despite medication use.
- Pharmacists are suggested to advise on drug combinations to improve disease management.

## Abstract

Background: Because patients often already have coronary artery disease (CAD) at the time of a coronary artery computed tomography angiography (CCTA) examination, we examined the medications prescribed by medical doctors for lifestyle-related diseases and investigated what possible role pharmacists can play in prescribing. Methods: Patients (n = 1357) who underwent CCTA examination were divided into two groups according to the presence or absence of lifestyle-related diseases [hypertension (HTN), dyslipidemia (DL) and diabetes mellitus (DM)], and the relationship between the presence or absence of CAD was examined. Results: The rate of CAD was significantly higher in patients with HTN, DL or DM than in patients without these diseases. The blood pressure in the HTN group was 140 ± 20/79 ± 13 mmHg, the low-density lipoprotein cholesterol value in the DL group was 119 ± 35 mg/dL, and the hemoglobin A1c value in the DM group was 7.0 ± 1.1%, all of which were poorly controlled. Anti-hypertensive drugs were used at low rates in the HTN group, statins were used in 47% and ezetimibe was used in 4% of the DL group, and dipeptidyl peptidase-4 inhibitors were used in 41% of the DM group. Conclusions: Since the rate of CAD (+) was high and control of the three major lifestyle-related diseases was poor, pharmacists should advise medical doctors to use combinations of drugs.

## Linked entities

- **Diseases:** coronary artery disease (MONDO:0005010), dyslipidemia (MONDO:0002525), diabetes mellitus (MONDO:0005015)

## Full-text entities

- **Diseases:** DM (MESH:D003920), HTN (MESH:D006973), CAD (MESH:D003324), Diseases (MESH:D004194), DL (MESH:D050171), Lifestyle-Related Diseases (MESH:D000077733)
- **Chemicals:** Anti- (-), ezetimibe (MESH:D000069438)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11270262/full.md

---
Source: https://tomesphere.com/paper/PMC11270262